SK279018B6 - Kryštalická forma n-[4-[5-(cyklopentyloxykarbonyl) - Google Patents

Kryštalická forma n-[4-[5-(cyklopentyloxykarbonyl) Download PDF

Info

Publication number
SK279018B6
SK279018B6 SK3758-91A SK375891A SK279018B6 SK 279018 B6 SK279018 B6 SK 279018B6 SK 375891 A SK375891 A SK 375891A SK 279018 B6 SK279018 B6 SK 279018B6
Authority
SK
Slovakia
Prior art keywords
methoxybenzoyl
ylmethyl
methylindol
amino
months
Prior art date
Application number
SK3758-91A
Other languages
English (en)
Slovak (sk)
Inventor
Martin P. Edwards
John D. Sherwood
Original Assignee
Zeneca Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Limited filed Critical Zeneca Limited
Publication of SK279018B6 publication Critical patent/SK279018B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK3758-91A 1990-12-12 1991-12-11 Kryštalická forma n-[4-[5-(cyklopentyloxykarbonyl) SK279018B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027018A GB9027018D0 (en) 1990-12-12 1990-12-12 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
SK279018B6 true SK279018B6 (sk) 1998-05-06

Family

ID=10686919

Family Applications (1)

Application Number Title Priority Date Filing Date
SK3758-91A SK279018B6 (sk) 1990-12-12 1991-12-11 Kryštalická forma n-[4-[5-(cyklopentyloxykarbonyl)

Country Status (28)

Country Link
US (1) US5294636A (fr)
EP (1) EP0490649B1 (fr)
JP (1) JP2650807B2 (fr)
KR (1) KR100194479B1 (fr)
CN (2) CN1032469C (fr)
AP (1) AP286A (fr)
AT (1) ATE145199T1 (fr)
AU (1) AU656344B2 (fr)
CA (1) CA2056067C (fr)
CZ (1) CZ288151B6 (fr)
DE (1) DE69123123T2 (fr)
DK (1) DK0490649T3 (fr)
ES (1) ES2094797T3 (fr)
FI (1) FI101296B (fr)
GB (2) GB9027018D0 (fr)
GR (1) GR3021605T3 (fr)
HK (1) HK81497A (fr)
HU (2) HU213109B (fr)
IE (1) IE914316A1 (fr)
IL (1) IL100090A (fr)
MX (1) MX9102475A (fr)
MY (1) MY108629A (fr)
NZ (1) NZ240940A (fr)
PH (1) PH30041A (fr)
RU (1) RU2107682C1 (fr)
SK (1) SK279018B6 (fr)
TW (1) TW222264B (fr)
ZA (1) ZA919772B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE113581T1 (de) * 1990-05-04 1994-11-15 Ciba Geigy Ag Substituierte indole.
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
GR1001368B (el) * 1992-10-08 1993-10-29 Ici Plc Φαρμακευτικοί φορείς.
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
WO1995009615A1 (fr) * 1993-10-01 1995-04-13 Astra Aktiebolag Procede (i)
GB9723985D0 (en) * 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
IL139243A0 (en) * 2000-10-24 2001-11-25 Internat Specialty Products Is Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
JP2008531721A (ja) * 2005-03-03 2008-08-14 エラン・ファルマ・インターナショナル・リミテッド 複素環式アミド誘導体のナノ粒子状組成物
US20070197467A1 (en) * 2006-02-06 2007-08-23 Srinivasulu Rangineni Zafirlukast compositions
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
JP2010535234A (ja) * 2007-07-30 2010-11-18 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換インドール
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
WO2014012954A1 (fr) 2012-07-18 2014-01-23 Takeda Gmbh Traitement de l'asthme sévère partiellement régulé ou non régulé
CN103396353B (zh) * 2013-08-23 2015-05-20 海南通用三洋药业有限公司 一种扎鲁司特无定型态及其制备方法
EP3096760A1 (fr) 2014-01-22 2016-11-30 Takeda GmbH Traitement de l'asthme grave partiellement contrôlé ou non contrôlé avec un inhibiteur de pde4 (et en combinaison avec un modificateur des leucotriènes)
PT109030B (pt) 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
WO2018140858A1 (fr) 2017-01-30 2018-08-02 Western New England University Inhibiteurs de thiol isomérases et leur utilisation
AU2022276190A1 (en) 2021-05-19 2024-01-18 Quercis Pharma AG Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis
WO2023214391A1 (fr) 2022-05-06 2023-11-09 Quercis Pharma AG Méthode de traitement de cancers et de maladies neurologiques à l'aide de compositions contenant de la quercétine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives

Also Published As

Publication number Publication date
GB2250743A (en) 1992-06-17
CS375891A3 (en) 1992-06-17
FI101296B1 (fi) 1998-05-29
IL100090A0 (en) 1992-08-18
GR3021605T3 (en) 1997-02-28
AP9100341A0 (en) 1992-01-31
CN1032469C (zh) 1996-08-07
HU213109B (en) 1997-02-28
JPH04266872A (ja) 1992-09-22
GB2250743B (en) 1995-02-15
CN1074411C (zh) 2001-11-07
FI101296B (fi) 1998-05-29
MY108629A (en) 1996-10-31
ATE145199T1 (de) 1996-11-15
AU8899591A (en) 1992-06-18
AU656344B2 (en) 1995-02-02
CA2056067C (fr) 2001-09-04
AP286A (en) 1993-09-26
FI915825A (fi) 1992-06-13
RU2107682C1 (ru) 1998-03-27
EP0490649A1 (fr) 1992-06-17
HK81497A (en) 1997-06-27
DK0490649T3 (da) 1997-04-21
ES2094797T3 (es) 1997-02-01
CN1063100A (zh) 1992-07-29
ZA919772B (en) 1992-09-30
CN1148491A (zh) 1997-04-30
IL100090A (en) 1996-09-12
GB9126353D0 (en) 1992-02-12
CA2056067A1 (fr) 1992-06-13
HU211125A9 (en) 1995-10-30
PH30041A (en) 1996-11-08
KR100194479B1 (ko) 1999-06-15
FI915825A0 (fi) 1991-12-11
HUT60717A (en) 1992-10-28
TW222264B (fr) 1994-04-11
NZ240940A (en) 1994-05-26
IE914316A1 (en) 1992-06-17
EP0490649B1 (fr) 1996-11-13
DE69123123D1 (de) 1996-12-19
JP2650807B2 (ja) 1997-09-10
HU913863D0 (en) 1992-02-28
MX9102475A (es) 1992-06-01
DE69123123T2 (de) 1997-03-06
US5294636A (en) 1994-03-15
KR920012031A (ko) 1992-07-25
CZ288151B6 (en) 2001-05-16
GB9027018D0 (en) 1991-01-30

Similar Documents

Publication Publication Date Title
SK279018B6 (sk) Kryštalická forma n-[4-[5-(cyklopentyloxykarbonyl)
KR100207802B1 (ko) N-[4-(5-시클로펜틸옥시카르보닐)아미노-1-메틸인돌-3-일-메틸]-3-메톡시벤조일]-2-메틸벤젠설폰아미드 화합물 및 이것의 제조 방법
AU3095600A (en) New pharmaceutical formulation
FI106021B (fi) Menetelmä N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi
PT100507B (pt) Nova forma fisica de derivados de amidas heterociclicos, processo para a sua preparacao e composicoes farmaceuticas que os contem
NO179575B (no) Farmasöytisk preparat inneholdende en fysikalsk form av forbindelsen N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetyl-3-metoksybenzoylÅ-2-metylbenzensulfonamid